Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.

Pharmacogenomics - 1 Apr 2010

Huang R Stephanie, Dolan M Eileen

Abstract excerpt

Pharmacogenomics is emerging as an important component both in facilitating new drug development and in improving the utility of existing chemotherapeutic agents. Both candidate gene and genome-wide approaches have been used to identify genetic markers associated with chemotherapeutic response and/or toxicity. New molecular targeted agents have been designed based on a sophisticated understanding of the molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers
Share to Drug Discovery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genome, Human

Share to Models, Biological

Share to Neoplasms

Share to Pharmacogenetics

Source

Open in PubMed Open full text

Identifiers

PMID: 20350124
DOI: 10.2217/pgs.10.11
PMCID: PMC2864525

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.PMID 20350124Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

Application of pharmacogenetics in oncologySemantic proximity Read ↗

Cancer pharmacogenetics.Semantic proximity Read ↗

Clinically relevant cancer biomarkers and pharmacogenetic assays.Semantic proximity Read ↗

Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity.Semantic proximity Read ↗

Cancer Pharmacogenomics: Early Promise, But Concerted Effort NeededSemantic proximity Read ↗

Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.Semantic proximity Read ↗

Pharmacogenomic discovery approaches: will the real genes please stand up?Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapySemantic proximity Read ↗

Pharmacogenetics in the cancer clinic: from candidate gene studies to next-generation sequencing.Semantic proximity Read ↗

Cancer Treatment in the Genomic EraSemantic proximity Read ↗

Cancer pharmacogenetics: polymorphisms, pathways and beyond.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.